Influenza Virus Neuraminidase Inhibitors: Generation and Comparison of Structure-Based and Common Feature Pharmacophore Hypotheses and Their Application in Virtual Screening. - Theodora M. Steindl; Thierry Langer (J. Chem. Inf. Model., 2004)

Human Rhinovirus 3C Protease: Generation of Pharmacophore Models for Peptidic and Nonpeptidic Inhibitors and Their Application in Virtual Screening. - Theodora M. Steindl; Christian Laggner; Thierry Langer (J. Chem. Inf. Model., 2005)

High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening. - Theodora M. Steindl; Daniela Schuster 001; Gerhard Wolber; Christian Laggner; Thierry Langer (J. Comput. Aided Mol. Des., 2006)

Pharmacophore Modeling and in Silico Screening for New P450 19 (Aromatase) Inhibitors. - Daniela Schuster 001; Christian Laggner; Theodora M. Steindl; Anja Palusczak; Rolf W. Hartmann; Thierry Langer (J. Chem. Inf. Model., 2006)

Parallel Screening: A Novel Concept in Pharmacophore Modeling and Virtual Screening. - Theodora M. Steindl; Daniela Schuster 001; Christian Laggner; Thierry Langer (J. Chem. Inf. Model., 2006)

Parallel Screening and Activity Profiling with HIV Protease Inhibitor Pharmacophore Models. - Theodora M. Steindl; Daniela Schuster 001; Christian Laggner; Karen Chuang; Rémy D. Hoffmann; Thierry Langer (J. Chem. Inf. Model., 2007)